BioPharma Dive 2. Dez. 2025 Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair
BioPharma Dive 1. Dez. 2025 Expanding access in oncology trials: The case for a paired tissue-plasma approach
BioPharma Dive 1. Dez. 2025 Specialty pharmacy’s secret weapon: The unsung power of the enrollment form
BioPharma Dive 26. Nov. 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
BioPharma Dive 26. Nov. 2025 Otsuka gains approval for first-of-its-kind treatment against rare kidney disease